A patient said something to me this week that I’ve heard more than once:

“My doctor said he wasn’t sure which one to prescribe because there are so many options.”

He shared this after we reviewed the differences between his new blood pressure medication and his previous one (Metoprolol). His real question was simple: “Is this a better choice?”

From a clinician’s perspective, I understand exactly what his provider meant. Hypertension management truly does come with a wide range of therapeutic options.

But from a patient’s perspective, that statement can feel like uncertainty rather than clinical reasoning.

This is where transparent decision‑making matters. Guidelines give us a foundation, but in practice, clinicians often need a quick, structured way to narrow choices without overwhelming themselves or the patient.

Here’s a suggested framework, from a pharmacist’s lens, to support pharmacotherapeutic decisions:

1. Start with the class that offers the lowest risk for the patient’s profile, e.g., Thiazides, ACEIs, ARBs, CCBs, Beta‑blockers.
   Each class has strengths and limitations depending on comorbidities, labs, and tolerability. Patients will not adhere to medications that make them feel bad, no matter how strong the evidence is.
   
2. Then consider the class with the highest potential benefit.
   Which class aligns best with their medical history – cardiac history, kidney function, or symptom pattern? This step helps ensure the therapy is not only safe but meaningful.
   
3. Evaluate cost‑effectiveness and access.
   The “best” medication loses its value if the patient can’t afford it, can’t access it, or won’t take it consistently. If it’s not practical, it’s not happening – practicality is part of clinical excellence.
   
4. Once the class is chosen, compare within the class
   This is where the conversation becomes focused and manageable. If an ARB is most appropriate, the decision shifts to which one of them eg Losartan vs Olmesartan vs Telmisartan vs Valsartan, rather than “which of all the 20+ BP medications should I pick?”

This approach should help patients feel reassured, help clinicians feel grounded, and help the care plan feel intentional rather than arbitrary.

To the clinicians reading this, what’s your go‑to framework when multiple first‑line medication options exist?

I’d love to hear how you navigate these conversations in your practice!

~Dr. Ahunna Freeman